BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22917038)

  • 1. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the utility of unselected coagulation screening in general hospital practice.
    McHugh J; Holt C; O'Keeffe D
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration of hemostasis in current practice].
    Aiach M; Gaussem P
    Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the use of coagulation test panels.
    Amukele TK; Baird GS; Chandler WL
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):688-95. PubMed ID: 21934488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
    Santoro RC; Molinari AC; Leotta M; Martini T
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
    Rasmussen KL; Philips M; Tripodi A; Goetze JP
    Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired coagulation disorders].
    Suzuki N
    Rinsho Ketsueki; 2020; 61(7):779-784. PubMed ID: 32759565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of bleeding disorders. Basic screening tests.
    Palmer RL
    Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
    Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
    J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
    Song J; Jung HW; Lee EH; Chang HK; Yoon HS
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
    Tripodi A; Chantarangkul V; Mannucci PM
    Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.